
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gastrointestinal hormones and weight management
George A. Bray
The Lancet (2009) Vol. 374, Iss. 9701, pp. 1570-1571
Closed Access | Times Cited: 11
George A. Bray
The Lancet (2009) Vol. 374, Iss. 9701, pp. 1570-1571
Closed Access | Times Cited: 11
Showing 11 citing articles:
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield, et al.
International Journal of Obesity (2012) Vol. 37, Iss. 6, pp. 828-834
Open Access | Times Cited: 2043
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield, et al.
International Journal of Obesity (2012) Vol. 37, Iss. 6, pp. 828-834
Open Access | Times Cited: 2043
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
Minako Yamaoka‐Tojo, Taiki Tojo, Naonobu Takahira, et al.
Cardiovascular Diabetology (2010) Vol. 9, Iss. 1, pp. 17-17
Open Access | Times Cited: 83
Minako Yamaoka‐Tojo, Taiki Tojo, Naonobu Takahira, et al.
Cardiovascular Diabetology (2010) Vol. 9, Iss. 1, pp. 17-17
Open Access | Times Cited: 83
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield, et al.
International Journal of Obesity (2012) Vol. 37, Iss. 6, pp. 828-834
Open Access | Times Cited: 42
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield, et al.
International Journal of Obesity (2012) Vol. 37, Iss. 6, pp. 828-834
Open Access | Times Cited: 42
Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes
Anne Ottney
American Journal of Health-System Pharmacy (2013) Vol. 70, Iss. 23, pp. 2097-2103
Closed Access | Times Cited: 24
Anne Ottney
American Journal of Health-System Pharmacy (2013) Vol. 70, Iss. 23, pp. 2097-2103
Closed Access | Times Cited: 24
Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis
Nicholas R. Fuller, Hannah Carter, Deborah Schofield, et al.
International Journal of Obesity (2013) Vol. 38, Iss. 8, pp. 1104-1109
Open Access | Times Cited: 24
Nicholas R. Fuller, Hannah Carter, Deborah Schofield, et al.
International Journal of Obesity (2013) Vol. 38, Iss. 8, pp. 1104-1109
Open Access | Times Cited: 24
Advances in the treatment of prediabetes
Glenn Matfin, Richard E. Pratley
Therapeutic Advances in Endocrinology and Metabolism (2010) Vol. 1, Iss. 1, pp. 5-14
Open Access | Times Cited: 21
Glenn Matfin, Richard E. Pratley
Therapeutic Advances in Endocrinology and Metabolism (2010) Vol. 1, Iss. 1, pp. 5-14
Open Access | Times Cited: 21
Advances in Medical Therapy for Weight Loss and the Weight-Centric Management of Type 2 Diabetes Mellitus
Leon I. Igel, Amanda G. Powell, Caroline M. Apovian, et al.
Current Atherosclerosis Reports (2011) Vol. 14, Iss. 1, pp. 60-69
Closed Access | Times Cited: 20
Leon I. Igel, Amanda G. Powell, Caroline M. Apovian, et al.
Current Atherosclerosis Reports (2011) Vol. 14, Iss. 1, pp. 60-69
Closed Access | Times Cited: 20
Basal Glucagonlike Peptide 1 Levels and Metabolic Syndrome in Obese Patients
Daniel Antonio de Luis, R. Aller, R. Conde, et al.
Journal of Investigative Medicine (2012) Vol. 60, Iss. 6, pp. 874-877
Closed Access | Times Cited: 11
Daniel Antonio de Luis, R. Aller, R. Conde, et al.
Journal of Investigative Medicine (2012) Vol. 60, Iss. 6, pp. 874-877
Closed Access | Times Cited: 11
Liraglutide pour le traitement du diabète de type 2
A. Avignon, J.-P. Sauvanet
Médecine des Maladies Métaboliques (2010) Vol. 4, Iss. 3, pp. 313-325
Closed Access | Times Cited: 2
A. Avignon, J.-P. Sauvanet
Médecine des Maladies Métaboliques (2010) Vol. 4, Iss. 3, pp. 313-325
Closed Access | Times Cited: 2
Current World Literature
Current Opinion in Endocrinology Diabetes and Obesity (2011) Vol. 18, Iss. 1, pp. 83-98
Closed Access
Current Opinion in Endocrinology Diabetes and Obesity (2011) Vol. 18, Iss. 1, pp. 83-98
Closed Access